These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 24858274)

  • 101. microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.
    Nagaraj S; Zoltowska KM; Laskowska-Kaszub K; Wojda U
    Ageing Res Rev; 2019 Jan; 49():125-143. PubMed ID: 30391753
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.
    Du L; Pertsemlidis A
    J Mol Cell Biol; 2011 Jun; 3(3):176-80. PubMed ID: 21278200
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
    Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
    Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Lipids as Emerging Biomarkers in Neurodegenerative Diseases.
    Wei J; Wong LC; Boland S
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203300
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
    Teixeira Dos Santos MC; Bell R; da Costa AN
    Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
    [TBL] [Abstract][Full Text] [Related]  

  • 106. MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.
    Khezri MR; Yousefi K; Zolbanin NM; Ghasemnejad-Berenji M
    Mol Neurobiol; 2022 Mar; 59(3):1589-1603. PubMed ID: 35001356
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease.
    Schulte EC; Fukumori A; Mollenhauer B; Hor H; Arzberger T; Perneczky R; Kurz A; Diehl-Schmid J; Hüll M; Lichtner P; Eckstein G; Zimprich A; Haubenberger D; Pirker W; Brücke T; Bereznai B; Molnar MJ; Lorenzo-Betancor O; Pastor P; Peters A; Gieger C; Estivill X; Meitinger T; Kretzschmar HA; Trenkwalder C; Haass C; Winkelmann J
    Eur J Hum Genet; 2015 Oct; 23(10):1328-33. PubMed ID: 25604855
    [TBL] [Abstract][Full Text] [Related]  

  • 109. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
    Roshan R; Ghosh T; Scaria V; Pillai B
    Drug Discov Today; 2009 Dec; 14(23-24):1123-9. PubMed ID: 19822222
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases.
    Wu YY; Kuo HC
    J Biomed Sci; 2020 Apr; 27(1):49. PubMed ID: 32264890
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Blood biomarker-based classification study for neurodegenerative diseases.
    Kelly J; Moyeed R; Carroll C; Luo S; Li X
    Sci Rep; 2023 Oct; 13(1):17191. PubMed ID: 37821485
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Analysis of Micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer's Disease Biomarker Discovery.
    Takousis P
    Methods Mol Biol; 2018; 1750():283-292. PubMed ID: 29512080
    [TBL] [Abstract][Full Text] [Related]  

  • 113. A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease.
    Szelągowski A; Kozakiewicz M
    Oxid Med Cell Longev; 2023; 2023():7759053. PubMed ID: 37333462
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases.
    Balestri W; Sharma R; da Silva VA; Bobotis BC; Curle AJ; Kothakota V; Kalantarnia F; Hangad MV; Hoorfar M; Jones JL; Tremblay MÈ; El-Jawhari JJ; Willerth SM; Reinwald Y
    J Neuroinflammation; 2024 Jan; 21(1):32. PubMed ID: 38263227
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Unbiased approaches to biomarker discovery in neurodegenerative diseases.
    Chen-Plotkin AS
    Neuron; 2014 Nov; 84(3):594-607. PubMed ID: 25442938
    [TBL] [Abstract][Full Text] [Related]  

  • 116. A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.
    Reddy PH; Tonk S; Kumar S; Vijayan M; Kandimalla R; Kuruva CS; Reddy AP
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1156-1165. PubMed ID: 27524239
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA.
    Salemi M; Mogavero MP; Lanza G; Mongioì LM; Calogero AE; Ferri R
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741059
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.
    Teijido O; Cacabelos R
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332838
    [TBL] [Abstract][Full Text] [Related]  

  • 119. MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
    Nadim WD; Simion V; Benedetti H; Pichon C; Baril P; Morisset-Lopez S
    Curr Neuropharmacol; 2017; 15(2):260-275. PubMed ID: 27396304
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders.
    Perdoncin M; Konrad A; Wyner JR; Lohana S; Pillai SS; Pereira DG; Lakhani HV; Sodhi K
    Front Mol Neurosci; 2021; 14():756499. PubMed ID: 34690698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.